In addition, Patient N acquired a homozygous deleterious somatic mutation in BRCA1 (Frameshift in exon 17, rs80357572) (36 out of 43 reads carried mutation), and the ultramutated carcinoma (Patient D) acquired a VUS in BRCA1 (T231N). This evidence concerns the gene BRCA1 and carcinoma.